Establishment and pathological analyses of transgenic marmoset models of polyglutamine diseases
Project/Area Number |
26670446
|
Research Category |
Grant-in-Aid for Challenging Exploratory Research
|
Allocation Type | Multi-year Fund |
Research Field |
Neurology
|
Research Institution | National Center of Neurology and Psychiatry |
Principal Investigator |
NAGAI Yoshitaka 国立研究開発法人国立精神・神経医療研究センター, 神経研究所疾病研究第四部, 客員研究員 (60335354)
|
Co-Investigator(Renkei-kenkyūsha) |
SEKI Kazuhiko 国立研究開発法人国立精神・神経医療研究センター, 神経研究所モデル動物研究部, 部長 (00226630)
TOMIOKA Ikuo 信州大学, 先鋭領域融合研究群バイオメディカル研究所, 助教 (30528196)
|
Project Period (FY) |
2014-04-01 – 2016-03-31
|
Project Status |
Completed (Fiscal Year 2015)
|
Budget Amount *help |
¥3,640,000 (Direct Cost: ¥2,800,000、Indirect Cost: ¥840,000)
Fiscal Year 2015: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
Fiscal Year 2014: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
|
Keywords | 神経科学 / 脳神経疾患 / ポリグルタミン病 / 疾患モデル / 霊長類 / マーモセット / 遺伝子 / 神経変性疾患 |
Outline of Final Research Achievements |
In this study, aiming to establish non-human primate models of neurodegenerative diseases, we performed pathological analyses of transgenic marmoset models of Machado-Joseph disease (MJD)/spinocerebellar ataxia type 3, one of the polyglutamine diseases. We found that three of seven SCA3 transgenic marmosets, which expressed the mutant ataxin-3 transgene at higher levels, gradually developed progressive neurological symptoms such as motor impairment and muscle weakness. Neuropathological examinations revealed significant neurodegeneration accompanied with polyglutamine inclusions in their brains. We therefore conclude that our SCA3 transgenic marmosets faithfully recapitulate human SCA3 patients’ features, and are useful models for elucidating the pathophysiological mechanisms of and developing clinically-applicable therapies for neurodegenerative diseases.
|
Report
(3 results)
Research Products
(69 results)
-
[Journal Article] Molecular Basis of Orb2 Amyloidogenesis and Blockade of Memory Consolidation2016
Author(s)
Hervas R, Li L, Majumdar A, Fernandez-Ramirez Mdel C, Unruh JR, Slaughter BD, Galera-Prat A, Santana E, Suzuki M, Nagai Y, Bruix M, Casas-Tinto S, Menendez M, Laurents DV, Si K, Carrio-Vazquez M.
-
Journal Title
PLoS Biol
Volume: 26
Issue: 1
Pages: e1002361-e1002361
DOI
Related Report
Peer Reviewed / Open Access / Int'l Joint Research
-
-
-
-
[Journal Article] Synchrotron FTIR Micro-Spectroscopy for Structural Analysis of Lewy Bodies in the Brain of Parkinson’s Disease Patients2015
Author(s)
K. Araki, N. Yagi, Y. Ikemoto, S. Choong, H. Hayakawa, G. Beck, H. Sumi, H. Fujimura, T. Moriwaki, Y. Nagai, Y. Goto and H. Mochizuki
-
Journal Title
Scientific Reports
Volume: 5
Issue: 1
Pages: 17625-17625
DOI
NAID
Related Report
Peer Reviewed / Open Access / Int'l Joint Research
-
-
-
-
-
-
[Journal Article] p62 plays a protective role in the autophagic degradation of polyglutamine protein oligomers in polyglutamine disease model flies.2015
Author(s)
Saitoh Y, Fujikake N, Okamoto Y, Popiel HA, Hatanaka Y, Ueyama M, Suzuki M, Gaumer S, Murata M, Wada K, Nagai Y.
-
Journal Title
J Biol Chem
Volume: 290
Issue: 3
Pages: 1442-53
DOI
Related Report
Peer Reviewed / Open Access
-
-
[Journal Article] VPS35 dysfunction impairs lysosomal degradation of α-synuclein and exacerbates neurotoxicity in a Drosophila model of Parkinson's disease.2014
Author(s)
Miura E, Hasegawa T, Konno M, Suzuki M, Sugeno N, Fujikake N, Geisler S, Tabuchi M, Oshima R, Kikuchi A, Baba T, Wada K, Nagai Y, Takeda A, Aoki M.
-
Journal Title
Neurobio Dis
Volume: 71
Pages: 1-13
DOI
Related Report
Peer Reviewed
-
[Journal Article] Identification of ter94, Drosophila VCP, as a strong modulator of motor neuron degeneration induced by knockdown of Caz, Drosophila FUS2014
Author(s)
Azuma Y., Tokuda T., Shimamura M., Kyotani A., Sasayama H., Yoshida T., Mizuta I., Mizuno T., Nakagawa M., Fujikake N., Ueyama M., Nagai Y., Yamaguchi M
-
Journal Title
Hum. Mol. Genet
Volume: 23(13)
Issue: 13
Pages: 3467-3480
DOI
Related Report
Peer Reviewed
-
-
-
-
-
[Presentation] Establishment of a novel animal model of ALS/FTD expressing GGGGCC repeat RNA in Drosophila2015
Author(s)
Ueyama M., Ishiguro T., Fujikake N., Konno T., Koyama A., Onodera O., Ishikawa K., Wada K., Nagai Y.
Organizer
10th Brain Research Conference
Place of Presentation
Chicago, IL, USA
Year and Date
2015-10-15
Related Report
Int'l Joint Research
-
[Presentation] The SCA31-linked UGGAAexp repeat forms RNA foci and is translated into aggregating pentapeptide-repeat proteins in the SCA31 patient brain and Drosophila model.2015
Author(s)
Ishiguro T., Sato N., Fujikake N., Ueyama M., Yokota T., Mizusawa H., Wada K., Nagai Y., Ishikawa K.
Organizer
10th Brain Research Conference
Place of Presentation
Chicago, IL, USA
Year and Date
2015-10-15
Related Report
Int'l Joint Research
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
[Presentation] Expanded UGGAA repeat RNA associated with SCA31 causes progressive neurodegeneration in Drosophila.2014
Author(s)
Ishiguro T, Fujikake N, Sato N, Ueyama, M, Mizusawa H, Wada K, Nagai Y, Ishikawa K
Organizer
Cold Spring Harbor Laboratory 2014 Neurodegenerative Diseases meeting: Biology & Therapeutics
Place of Presentation
Cold Spring Harbor, NY, USA
Year and Date
2014-12-03 – 2014-12-06
Related Report
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-